The Biotech Resurgence Is Big Money’s Next Bet
Even though biotech has faced headwinds this year, I want readers to know that I haven’t “given up” on...
The Bleeding Edge is the only free newsletter that delivers daily insights and information from the high-tech world as well as topics and trends relevant to investments.
Even though biotech has faced headwinds this year, I want readers to know that I haven’t “given up” on...
The current climate has led me to assess our overall asset allocation plan. We need to be aware of...
When uncertainty is rampant, it can be difficult to remember that these transitory things will pass. That’s why it’s...
Helium has partnered up with FreedomFi for a wireless network, incentivizing regular people to run their own cells… But...
The Federal Reserve’s latest move to raise the Fed Funds rate by a meager 25 basis points from zero...
Jeff Brown has another exciting area of investment that can bring us truly generational wealth over time… And he’s...
The Bleeding Edge is the only free newsletter that delivers daily insights and information from the high-tech world as well as topics and trends relevant to investments.